NEJM Coskun T, Urva S, Roell WC, et al
GLP-1 (glucagon-like peptide-1) agonists represent a breakthrough class of medications originally developed for managing type 2 diabetes
The decision is yours, made with full information and medical guidance
A 2020 meta-analysis of 37 randomized controlled trials with over 2,200 participants found that L-carnitine supplementation led to an average weight loss of 1.21 kg, a slight drop in BMI, and a reduction in fat mass by about 2.08 kg, especially in people with overweight or obesity
This research was funded by the National Natural Science Foundation of China (NSFC No
Signe Srensen Torekov has received research grants and lecture fees and been on the advisory board for Novo Nordisk, and received a lecture fee Merck